| Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers WM Alenezi, CT Fierheller, N Recio, PN Tonin Genes 11 (8), 856, 2020 | 65 | 2020 |
| Cost-effectiveness of gene-specific prevention strategies for ovarian and breast cancer X Wei, L Sun, E Slade, CT Fierheller, S Oxley, A Kalra, J Sia, M Sideris, ... JAMA Network Open 7 (2), e2355324-e2355324, 2024 | 22 | 2024 |
| A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene CT Fierheller, L Guitton-Sert, WM Alenezi, T Revil, KK Oros, Y Gao, ... Genome medicine 13 (1), 1-26, 2021 | 20 | 2021 |
| The genetic analyses of French Canadians of Quebec facilitate the characterization of new cancer predisposing genes implicated in hereditary breast and/or ovarian cancer … CT Fierheller, WM Alenezi, PN Tonin Cancers 13 (14), 3406, 2021 | 20 | 2021 |
| The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique … WM Alenezi, L Milano, CT Fierheller, C Serruya, T Revil, KK Oros, S Behl, ... Cancers 14 (9), 2251, 2022 | 12 | 2022 |
| Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases WM Alenezi, CT Fierheller, C Serruya, T Revil, KK Oros, DN Subramanian, ... Frontiers in Oncology 13, 1111191, 2023 | 11 | 2023 |
| Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene CT Fierheller, WM Alenezi, C Serruya, T Revil, S Amuzu, K Bedard, ... Genes 14 (2), 277, 2023 | 10 | 2023 |
| Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic … WM Alenezi, CT Fierheller, T Revil, C Serruya, AM Mes-Masson, ... Genes 13 (4), 697, 2022 | 9 | 2022 |
| Cost-effectiveness of unselected multigene germline and somatic genetic testing for epithelial ovarian cancer R Manchanda, L Sun, M Sobocan, IV Rodriguez, X Wei, A Kalra, S Oxley, ... Journal of the National Comprehensive Cancer Network 22 (2D), 2024 | 8 | 2024 |
| Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysis A Kalra, S Ganesan, JJY Sia, KB Papalois, A Pandya, R Xiong, X Wei, ... American Journal of Obstetrics and Gynecology, 2025 | 6 | 2025 |
| Economic Evaluation of Population-Based BRCA1 and BRCA2 Testing in Canada L Sun, X Wei, CT Fierheller, L Dawson, S Oxley, A Kalra, J Sia, F Feldman, ... JAMA Network Open 7 (9), e2432725-e2432725, 2024 | 5 | 2024 |
| Defining lifetime risk thresholds for breast cancer surgical prevention X Wei, L Mansour, S Oxley, CT Fierheller, A Kalra, J Sia, S Ganesan, ... JAMA oncology 11 (9), 1072-1082, 2025 | 3 | 2025 |
| Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study M Sobocan, D Chandrasekaran, M Sideris, O Blyuss, C Fierheller, A Kalra, ... BJOG: An International Journal of Obstetrics & Gynaecology 131 (6), 848-857, 2024 | 2 | 2024 |
| Genetic and molecular analyses of candidate germline BRIP1/FANCJ variants implicated in breast and ovarian cancer L Milano, WM Alenezi, CT Fierheller, C Serruya, T Revil, KK Oros, J Bruce, ... medRxiv, 2023.07. 03.23290133, 2023 | 2 | 2023 |
| The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population. Cancers (Basel … WM Alenezi, L Milano, CT Fierheller, C Serruya, T Revil, KK Oros, S Behl, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 2 | 2022 |
| The genetic analysis of a founder Northern American population of European descent identifies FANCI as a candidate familial ovarian cancer risk gene CT Fierheller, L Guitton-Sert, WM Alenezi, T Revil, KK Oros, K Bedard, ... medRxiv, 2020.05. 04.20090407, 2020 | 2 | 2020 |
| Health-related quality of life after risk-reducing hysterectomy: a cross-sectional study of women with Lynch syndrome S Oxley, M Lake, A Dibden, A Brentnall, T Whenham, M Sideris, A Kalra, ... International Journal of Gynecological Cancer 35 (2), 2025 | 1 | 2025 |
| BRCA awareness and testing experience in the UK Jewish population: A qualitative study C Fierheller, K Sarig, S Oxley, A Kalra, M Sobocan, M Sideris, T Gootzen, ... Gynecologic Oncology 190, S162-S163, 2024 | 1 | 2024 |
| BRCA awareness and testing experience in the UK Jewish population: a qualitative study K Sarig, S Oxley, A Kalra, M Sobocan, CT Fierheller, M Sideris, T Gootzen, ... Journal of Medical Genetics 61 (7), 716-725, 2024 | 1 | 2024 |
| Utility Scores for Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy: Mapping to EQ-5D SG Oxley, X Wei, M Sideris, O Blyuss, A Kalra, JJY Sia, S Ganesan, ... Cancers 16 (7), 1358, 2024 | 1 | 2024 |
